CRINA Connects Seminar Series

The CRINA Connects Seminar Series showcases the innovative work being done by cancer researchers at the University of Alberta, and provides an opportunity for CRINA members to connect with and learn from other researchers around the world. The seminars are typically held each Wednesday at 12 noon (MT) from September to May.
2026-2027 CRINA Seminar series
Wednesday, September 9, 12pm (MT) on Zoom
Dr. Lara Mahal, "A Sweet Surprise: miRNA regulation of the glycome in cancer"
Wednesday, September 16, 12pm (MT) on Zoom
Dr. Liana Nobre, "Liquid Biopsy in Pediatric Brain Tumors: From Molecular Diagnosis to Disease Monitoring"
Wednesday, October 7, 12pm (MT) on Zoom
Dr. Mick Bhatia, "Defining human cancer stem cells for clinical impact: Prototyping Acute Myeloid Leukemia"
Thursday, October 15, 12pm (MT) in person
Dr. Sabine Elowe, "When Mitosis Goes Wrong: Kinase Signalling at the Crossroads of Disease”
Wednesday, October 21, 12pm (MT) on Zoom
Dr. Sandeep Gupta, "Human Neural Organoids: From Development to Disease Modeling"
Wednesday, October 28, 12pm (MT) on Zoom
Dr. Craig Jones
Wednesday, November 4, 12pm (MT) on Zoom
Dr. Jody Groenendyk
Wednesday, November 18, 12pm (MT) on Zoom
Dr. Susan Patricia Lees-Miller
Wednesday, November 25, 12pm (MT) on Zoom
Dr. Daniel Skubleny
Thursday, December 3, 12pm (MT) on Zoom
Dr. Roderick O'Sullivan
Wednesday, December 9, 12pm (MT) on Zoom
Dr. Afsaneh Lavasanifar
Previous Seminars
Monday, September 15, 2pm (MT) in Classroom F, WMC
Dr. Jeanette Boudreau, "Natural killer cell-based immunotherapies in solid tumours: The quest to conquer a hostile tumour microenvironment"
Wednesday, September 24, 12pm (MT) in Oborowsky Degner Seminar Hall, LKS
Dr. Girish Shah, "Role of PARP1 in transcription coupled nucleotide excision repair"
Wednesday, October 1, 12pm (MT) in Classroom D - 2F1.04, WMC
Dr. Jennifer Vena & Dr. Grace Shen-Tu, "Alberta’s Tomorrow Project – your provincial resource for cancer research"
Wednesday, October 15, 12pm (MT) on Zoom
Dr. Kathryn Rankin, "Outcomes that matter: CORe's role in oncology research"
Wednesday, October 29, 12pm (MT) on Zoom
Dr. Vickie Baracos, "Cancer cachexia: Latest findings"
Wednesday, November 5, 12pm (MT) in Classroom D - 2F1.04, WMC
Dr. Vera Mazurak, "Understanding disease-related malnutrition: A translational approach for nutritional interventions"
Wednesday, November 19, 12pm (MT) on Zoom
Dr. Troy Harkness, "Discovery of small peptides that increase yeast lifespan and reverse breast cancer cell drug resistance"
Wednesday, November 26, 12pm (MT) on Zoom
Dr. Marya Ahmed, "Understanding disease-related malnutrition: A translational approach for nutritional interventions"
Wednesday, December 3, 12pm (MT) in Classroom D - 2F1.04, WMC
Dr. Julian J. Lum, "Using metabolism to create next generation CAR-T cells"
Wednesday, December 10, 12 pm (MT) on Zoom
Dr. Denise Hemmings, "Impact of chronic cytomegalovirus infection on breast cancer metastasis"
Wednesday, January 14, 12pm (MT) on Zoom
Dr. Ryan Noyce, "Synthetic virology approaches to enhance oncolytic vaccinia virus therapeutics"
Wednesday, January 21, 9am (MT) on Zoom
Dr. Tim Witney, "Exploiting the vulnerabilities of drug-resistant cancer for imaging and therapy"
Wednesday, January 28, 12pm (MT) on Zoom
Dr. Emily Walker, "Cancer Care Alberta’s Precision Analytics Program: Using advanced modeling to anticipate future cancer care needs"
Thursday, February 5, 4pm (MT) in the Oborowsky Degner Seminar Hall
Dr. Amy Moran, "Androgen receptor signaling represents a novel mechanism of tumor immune evasion"
Wednesday, February 11, 12pm (MT) on Zoom
Mike Wong, "Accelerate your research through the FoMD Advanced Cell Exploration Core"
Wednesday, February 25, 12pm (MT) on Zoom
Dr. Anna Taylor, "Opioids and the immune system: challenges and opportunities for cancer pain"
Wednesday, March 4, 12pm (MT) in Classroom D - 2F1.04, WMC
Dr. Ayman Oweida, "Immune circuitry of radiotherapy resistance: Mechanisms and therapeutic opportunities"
Wednesday, March 11, 12pm (MT) on Zoom
Dr. Chris Le, "Therapeutic potential and toxicity of arsenic species"
Wednesday, March 18, 12pm (MT) on Zoom
Sara Elmahrouk, "Two Sexes, Two Responses: Arsenic Trioxide and Drug-Metabolizing Enzyme Regulation"
Wednesday, March 18, 12:30pm (MT) on Zoom
Daniel Delali, "Incidence of Primary Central Nervous System Tumours in Canada, 2018-2022"
Wednesday, March 25, 12pm (MT) on Zoom
Mohammad Nasrullah, "Targeted siRNA therapies for fusion oncogene-mediated blood cancers"
Wednesday, March 25, 12:30pm (MT) on Zoom
Harkeert Judge, "Research approaches advancing health equity capacity in cancer care systems"
Wednesday, April 8, 12pm (MT) on Zoom
Dr. Cheng-Han Lee, "Targeting immune evasion mechanisms associated with dedifferentiation in endometrial/ovarian cancer"
Wednesday, April 15, 12pm (MT) in Zane Feldman Auditorium, 2286 CCI
Dr. Armin Gamper, "Improving radiation therapy: Shifting from a tumour-centric to a patient-centric perspective"
Wednesday, April 22, 12pm (MT) on Zoom
Dr. Fraser Ferens, "Structural and biological evaluation of GGPPS inhibition as a therapeutic mechanism in acute myeloid leukemia"
Wednesday, April 22, 12pm (MT) on Zoom
Dr. Shayla Mosley, "Genomic instability and cytosolic DNA: Turning the dial between hot and cold cytotoxic T cell responses in colorectal cancer"
Wednesday, April 29, 12pm (MT) on Zoom
Dr. Emilia Lim, "Environmental oncogenomics - Investigating how air pollution promotes lung cancer"
Wednesday, May 6, 12pm (MT) in Classroom D - 2F1.04, WMC
Dr. Aaron Goodarzi, "Radioactive Air Pollutant Induced Disease (RAPID) Prevention: Understanding and preventing lung cancer risks from particle radiation-emitting radioisotope inhalation"
Wednesday, May 13, 12pm (MT) on Zoom
No Seminar
Wednesday, May 20, 12pm (MT) on Zoom
Larry Fliegel, "pH Deregulation as the Eleventh Hallmark of Cancer"
Friday, May 29, 12pm (MT) in the Oborowsky Degner Seminar Hall
Tomoya Uehara, "Development of astatine-211-labeled compounds for cancer radionuclide therapy"
Wednesday, June 17, 12 pm (MT) in 2-490 Kipnes Health Research Academy
Sherri Christian, "Extracellular vesicles in B cell development and leukemia"
September 4, 2024: Dr. Hanne Ostergaard, "CRINA peer review and grant support"
September 11, 2024: Dr. Jason Northey, ""Mechanoregulation of hormone-dependent cell plasticity in breast cancer progression""
September 18, 2024: Dr. Dean Chamberlain, "3D microtissue models of breast and ovarian cancer" * In-Person (Bernard Snell Hall)
September 25, 2024: Dr. Edan Foley, "Oh my NOD! Immune regulation of intestinal homeostasis"
October 30, 2024: Dr. Nicolas Jacquelot, "Harnessing type 2 innate lymphoid cells in cancer" * In-Person (ECHA L1-430)
November 6, 2024: Danielle Simonot, "Presenting the Alberta Cancer Research Biobank (ACRB): Providing Samples and Data to Alberta Researchers Since (at least) 2002"
November 20, 2024: Dr. Reza Mirzaei, "Understanding the Tumor Microenvironment to Improve Immunotherapy in Cold Tumors"
November 27, 2024: Dr. John Lewis, "Development of highly selective genetic medicines as cancer therapeutics"
December 11, 2024: Dr. Gopinath Sutendra, "Can tissue-specific differences in redox status provide therapeutic selectivity in cardio-oncology?"
December 18, 2024: Dr. Shane Harding, "Micronuclei as a window to the DNA damage response" *In-Person (ECHA 2-190)
January 8, 2025: Dr. Andrew Mason ""Human betaretrovirus, autoimmunity and breast cancer"
January 22, 2025: Dr. Richard Fahlman, "Emerging Technologies and Applications in Proteomics for Mechanistic and Clinical Studies"
January 29, 2025: Dr. Jack Tuszyński, "Investigations of the effects of electric and electromagnetic fields on cancer cells and the cytoskeleton"
February 5, 2025: Dr. Lynne-Marie Postovit, "Mechanistic Underpinnings of Cancer Cell Plasticity"
February 12, 2025: Dr. Lisa Willis, "Polysialylation is a general feature of immune activation"
February 26, 2025: Dr. Catherine Field, "Results of the primary and secondary outcomes of the DHA-Win Trial in women with breast cancer"
March 5, 2025: Dr. Ivan Bogeski, "Calcium and Redox Signals at Cellular Interfaces: Implications for Cancer and Immunity: *In-Person (ECHA 1-490)
March 12, 2025: Dr. Ismail Ismail, "MAEA: A New Piece in the DNA Repair Puzzle" *In-Person (ECHA 2-420)
March 19, 2025: Dr. Arno Siraki, "Drug-Induced Free Radical Formation in Neutrophils and Promyelocytic Leukemia Cells – What is the Common Link?"
March 26, 2025: Dr. Russ Greiner, "Working with Medical Colleagues to Produce Effective Prediction Systems"
April 2, 2025: Dr. Konstantin Stoletov, "Adrenomedullin 2 as a Driver of Cancer Cell Intravasation: Intravital Discovery"
April 9, 2025: Dr. Costin Antonescu "Receptor signaling at the nanoscale: how organization of signals at the plasma membrane regulate signaling specificity and outcome"
April 16, 2025: Ghada Aborkees, "Title: Leukemic Lymphoblasts Express Hemostatic System Factors: Mechanisms and Biomarkers for VTE Risk"
April 30, 2025: Dr. Jenilee Woodfield, "Targeting ubiquitin-specific protease 14 (USP14): An innovative biomarker for molecular imaging of multiple myeloma" & Dr. Connie Le, "Combining Radiotherapy and Immunotherapy to treat Hepatocellular Carcinoma"
May 7, 2025: Sharon Basaraba, “Long Story Short: How to Write a Lay Summary”
May 21, 2025: Dr. Simon Gravel, "Tracking cancer risk in (very) large genealogies"
May 28, 2025: Dr. David Wishart, "How Metabolomics Facilitates a Multi-omics View on Cancer"
ACF Game Changer Grant Seminars x CRINA Connects
October 3, 2024: Dr. Roseline Godbout, “Investigating the link between metabolism and prostate cancer progression”* In-Person (Michael J. Hutchinson, 2279 Cross Cancer Institute)
October 10, 2024: Dr. Ing Swie Goping, "A patient-derived organoid platform for next-level breast cancer research” * In-Person (Zane Feldman Auditorium, 2286 Cross Cancer Institute)
October 17, 2024: Dr. Vickie Baracos, "Cancer cachexia: breaking the spiral of wasting and treatment toxicity” * In-Person (Zane Feldman Auditorium, 2286 Cross Cancer Institute)
October 24, 2024: Dr. Kristi Baker, “Immune resistance mechanisms in late-stage genetically unstable cancers” * In-Person (Zane Feldman Auditorium, 2286 Cross Cancer Institute)
Learn about the Game Changer Grant